David G. Marrero, PhD, advocated for a social-ecological model to better understand and integrate diabetes care in a symposium focused on preserving mental health across the lifespan of living with this disease.
Kelly M. Rawlings, MS, and Marci Butcher, RD, LN, CDCES, FADCES, will discuss digital health and diabetes support in a two-hour symposium Monday afternoon.
Maureen Monaghan, PhD, CDCES, Samantha Kleinberg, PhD, and Jennifer Raymond, MD, MCR, will offer insight into navigating the diabetes digital landscape.
An expert panel including Kathryn Haskins, PhD, Teresa P. DiLorenzo, PhD, and Megan K. Levins, PhD, will discuss the past, present, and future of T cells in diabetes treatment.
Carlos A. Monteiro, MD, PhD, will share data on the effects of ultraprocessed foods, while Sung Kyun Park, ScD, MPH, will provide data on per- and polyfluoroalkyl substances.
Raghavendra Rao, MD, Charles Stanley, MD, Sarbattama Sen, MD, and Paul Rozance, MD, will address whether neonatal hypoglycemia is overdiagnosed or underestimated in this symposium.
A joint symposium of the ADA and the International Society for Pediatric and Adolescent Diabetes featuring Richard A. Oram, MD, PhD, and R. Brett McQueen, PhD, will consider general population screening versus targeted screening.
The data from continuous glucose monitoring devices can help patients make more informed decisions on lifestyle modifications, insulin dosing, and meal planning. Thomas W. Martens, MD, Dana Gershenoff, MS, RD, CDCES, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, explain how.
Dana M. Lewis, BA, shared details about her presentation at the 81st Scientific Sessions on evidence supporting the use of open-source automated insulin delivery systems. “Many providers are still unaware of them as an option, or how they might support patients choosing to access these systems,” she said.
Shuibing Chen, PhD, shared details about this presentation, which begins Sunday, June 27, at 6:00 p.m. ET.